Skip to main content
  • Our portfolio companies are a top priority.

    We finance new therapies and medical technologies to improve patient outcomes and build value for investors.

  • “TVM incorporates teamwork into its culture of working with biotech companies, creating a strong framework for successful collaboration.”
    Michael Salzmann, PhD, CEO, AL-S Pharma
  • “TVM has not just provided the capital to accelerate our growth, but they also bring a wealth of experience and top-notch advisors who add value across the operational spectrum.”

    Pierre Lemire, CEO, Kent Imaging

Home   >  Portfolio

We work closely with our portfolio companies, striving to understand their ideas and enable them to develop their innovations to ultimately bring new therapies and medical technologies to market. By investing in lasting partnerships, we have facilitated the development of leading products and services, recruited world-class management and gained a strong foothold in the North American and European markets.